“Bayer has been working to improve women’s health in Australia for more than 60 years, and with the PBS listing of YAZ and YASMIN, we are proud to demonstrate this commitment to advancing women’s health by providing solutions for her different reproductive needs," said Manoj Saxena, CEO of Bayer Australia and New Zealand and country division head for the pharmaceutical division
A 'milestone moment' with first oral contraceptive listed on the PBS in over 30 years
March 2, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
There is an ideology behind our funding systems, and it's the greatest barrier to change
March 11, 2026 - - Latest News -
New patient-led tool launched in Canberra to transform pain communication
March 10, 2026 - - Latest News -
Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs
March 10, 2026 - -
New digital partnership expands access to clinical guidance for Australian healthcare professionals
March 10, 2026 - - Latest News -
Self injection option offers new flexibility for Australians living with Myasthenia Gravis
March 10, 2026 - - Latest News -
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - - Latest News -
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - - Latest News

